Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced Malignancies, Non-small Cell Lung Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT00561054
What this trial is testing

Efficacy and Safety of Cetuximab in Combination With Cisplatin Gemcitabine as First-Line Therapy in Advanced NSCLC

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Grupo Portugues de Estudo do Cancro do Pulmao 47
Testing effectiveness (Phase 2)Ended earlyNCT00955305
What this trial is testing

Paclitaxel, Carboplatin, and Bevacizumab With or Without Cixutumumab in Treating Patients With Stage IV or Recurrent Non-small Cell Lung Cancer

Who this might be right for
Large Cell Lung CarcinomaLung AdenocarcinomaRecurrent Non-Small Cell Lung Carcinoma+2 more
National Cancer Institute (NCI) 175
Testing effectiveness (Phase 2)Study completedNCT00454194
What this trial is testing

Pemetrexed Disodium With or Without Sorafenib as Second-Line Therapy in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Alliance for Clinical Trials in Oncology 110
Testing effectiveness (Phase 2)Study completedNCT00682383
What this trial is testing

Combined Modality Therapy With Growth Factor Support in Locally Advanced Non-small Cell Lung Cancer (NSCLC)

Who this might be right for
Unresectable Locally Advanced NSCLC
Mt. Sinai Medical Center, Miami 26
Post-approval studies (Phase 4)Study completedNCT01230710
What this trial is testing

Tarceva (Erlotinib) in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer Following 4 Cycles of Platinum-based Chemotherapy Without Disease Progression

Who this might be right for
Non-Small Cell Lung Cancer
Hoffmann-La Roche 51
Testing effectiveness (Phase 2)UnknownNCT03420079
What this trial is testing

A Phase I Study of FCN-411 in Advanced Non-small Cell Lung Cancer Chinese Patients With EGFR Positive Mutation

Who this might be right for
Lung Cancer
Ahon Pharmaceutical Co., Ltd. 90
Early research (Phase 1)Study completedNCT02364362
What this trial is testing

Famitinib Plus Docetaxel in Patients With Advanced Non-squamous and Non-Small Cell Lung Cancer (NSCLC)

Who this might be right for
Non-Small Cell Lung Cancer (NSCLC)
Jiangsu HengRui Medicine Co., Ltd. 18
Testing effectiveness (Phase 2)Study completedNCT00798603
What this trial is testing

Pemetrexed, Carboplatin, and Bevacizumab as First-Line Therapy in Treating Older Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Alliance for Clinical Trials in Oncology 65
Not applicableStudy completedNCT03370770
What this trial is testing

Afatinib Osimertinib Sequencing NIS

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Boehringer Ingelheim 204
Testing effectiveness (Phase 2)WithdrawnNCT03692780
What this trial is testing

Careseng 1370 for Chemotherapy-Induced Myelosuppression

Who this might be right for
Chemotherapy-Induced Myelosuppression
Careseng Biotech Co., Ltd.
Not applicableUnknownNCT03077854
What this trial is testing

Image-Guided Functional Lung Avoidance Thoracic Radiotherapy for Lung Cancer: A Single-Blind Randomized Trial

Who this might be right for
Small Cell Lung Cancer, Limited StageStage III Non-small Cell Lung Cancer
National Taiwan University Hospital 64
Large-scale testing (Phase 3)Study completedNCT00556322
What this trial is testing

Tarceva (Erlotinib) and Standard of Care Chemotherapy in Patients With Advanced, Recurrent, or Metastatic Non-Small Cell Lung Cancer (NSCLC)

Who this might be right for
Non-Small Cell Lung Cancer
Hoffmann-La Roche 424
Not applicableUnknownNCT05815472
What this trial is testing

Advanced Patient Monitoring and A.I. Supported Outcomes Assessment in Lung Cancer Using Internet of Things Technologies (A.I. - APALITT)

Who this might be right for
Non-small-cell Lung Cancer
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 50
Early research (Phase 1)Active Not RecruitingNCT06781983
What this trial is testing

Safety and Tolerability of IPH4502 in Patients With Advanced Solid Tumors

Who this might be right for
Advanced or Metastatic Solid Tumors
Innate Pharma 145
Testing effectiveness (Phase 2)Active Not RecruitingNCT03620669
What this trial is testing

1st Line Durvalumab in PS 2 NSCLC Patients

Who this might be right for
NSCLC Stage IVNSCLC Stage IIIB
Swiss Cancer Institute 48
Testing effectiveness (Phase 2)Study completedNCT00723957
What this trial is testing

Phase 2 Study of Ixabepilone Plus Carboplatin and Paclitaxel Plus Carboplatin in Advanced Nonsmall-Cell Lung Cancer

Who this might be right for
Advanced/Metastatic Non-Small Cell Lung Cancer
R-Pharm 260
Testing effectiveness (Phase 2)Study completedNCT06139419
What this trial is testing

The Impact of Thymosin α-1 on the Efficacy of Concurrent Chemoradiotherapy Followed by Immunotherpay Consolidation for Locally Advanced NSCLC

Who this might be right for
Non-small Cell Lung Cancer
Sun Yat-sen University 114
Testing effectiveness (Phase 2)Looking for participantsNCT06092086
What this trial is testing

Lorlatinib as the First-line Treatment in China Advanced ALK+ NSCLC

Who this might be right for
ALK Positive Non-small Cell Lung Cancer
Guangdong Association of Clinical Trials 126
Testing effectiveness (Phase 2)UnknownNCT02688686
What this trial is testing

Safety and Efficacy of DC-CIK in Patients With Advanced Non-Small-Cell Lung Cancer With Bone Metastases

Who this might be right for
Non-Small-Cell Lung Cancer With Bone Metastases
Affiliated Hospital to Academy of Military Medical Sciences 30
Not applicableStudy completedNCT01963351
What this trial is testing

Bevacizumab in Combination With Chemotherapy in Patients With Advanced or Recurrent Non-squamous NSCLC

Who this might be right for
Non-small Cell Lung CancerUnresectable Malignant Neoplasm
University of Athens 150
Next Page